Correlation Between Viatris and Agios Pharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viatris and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and Agios Pharm, you can compare the effects of market volatilities on Viatris and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and Agios Pharm.

Diversification Opportunities for Viatris and Agios Pharm

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Viatris and Agios is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Viatris i.e., Viatris and Agios Pharm go up and down completely randomly.

Pair Corralation between Viatris and Agios Pharm

Given the investment horizon of 90 days Viatris is expected to generate 0.31 times more return on investment than Agios Pharm. However, Viatris is 3.27 times less risky than Agios Pharm. It trades about -0.19 of its potential returns per unit of risk. Agios Pharm is currently generating about -0.19 per unit of risk. If you would invest  1,309  in Viatris on November 29, 2024 and sell it today you would lose (185.00) from holding Viatris or give up 14.13% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Viatris  vs.  Agios Pharm

 Performance 
       Timeline  
Viatris 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Viatris has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Agios Pharm 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Agios Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Viatris and Agios Pharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viatris and Agios Pharm

The main advantage of trading using opposite Viatris and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.
The idea behind Viatris and Agios Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Fundamental Analysis
View fundamental data based on most recent published financial statements